Doctor Joris Komen
(Netherlands (The))
Follow
Contributor content
Journal
Persistence and predictors for non-persistence to edoxaban therapy in patients with atrial fibrillation: 4-year follow-up data from the ETNA-AF-Europe study
28 October 2024
